In a cohort of patients with OSCC, high METTL3 expression was correlated with low disease-free survival (Fig. 1D) and high tumor grade and lymph nodes metastasis (Fig. 1E, F), indicating that METTL3 overexpression is related to OSCC poor prognosis. Here, METTL3 is linked to neoplasm.